MetaCap

Royalty Pharma Insider Trades

NASDAQ: RPRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

56.64+0.43 (+0.76%)

Market open · Delayed 15 min · as of Oct 9, 10:19 AM ET

Last 12 months

Purchases
0 · $0
Sales
31 · $42.77M
Shares bought / sold
0 / 786.22K
Net activity
Net selling $42.8 million

Royalty Pharma insider activity

Over the last 12 months, Royalty Pharma insiders reported 54 transactions on SEC Form 4: 0 open-market purchases and 31 sales. Insiders bought $0 and sold $42.8 million worth of stock, for net insider selling of $42.8 million. The largest seller was Hite Christopher, with $27.4 million in reported sales.

The most recent filing shows Urist Marshall (EVP, Research & Investments) selling 4,126 shares at $57.10 on Oct 5, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RPRX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

RPRX insider transactions

Royalty Pharma insider transactions
DateInsiderTypeSharesValueFiling
Oct 5, 2026Urist MarshallEVP, Research & InvestmentsSale4,126$235.59KForm 4
Sep 30, 2026Bassler Bonnie LDirectorAward642$37.50KForm 4
Sep 28, 2026Urist MarshallEVP, Research & InvestmentsSale4,126$238.81KForm 4
Sep 22, 2026Hite ChristopherEVP & Chairman, PartneringSale3,927$231.40KForm 4
Sep 22, 2026Hite ChristopherEVP & Chairman, PartneringSale96,073$5.62MForm 4
Aug 19, 2026Hite ChristopherEVP & Chairman, PartneringGift16,800—Form 4
Aug 18, 2026Hite ChristopherEVP & Chairman, PartneringSale100,000$6.00MForm 4
Aug 13, 2026Coyne Terrance P.EVP & CFOSale1,772$104.80KForm 4
Aug 13, 2026Coyne Terrance P.EVP & CFOSale9,230$540.75KForm 4
Aug 5, 2026Urist MarshallEVP, Research & InvestmentsAward8,252—Form 4
Aug 5, 2026Hite ChristopherEVP & Chairman, PartneringAward11,002—Form 4
Aug 5, 2026Coyne Terrance P.EVP & CFOAward11,002—Form 4
Aug 5, 2026Legorreta Pablo G.CEO, Chairman of the BoardAward65,216—Form 4
Jul 1, 2026Urist MarshallEVP, Research & InvestmentsSale9,099$508.45KForm 4
Jun 30, 2026Bassler Bonnie LDirectorAward689$37.48KForm 4
Jun 30, 2026Hite ChristopherEVP & Chairman, PartneringSale600$34.25KForm 4
Jun 30, 2026Hite ChristopherEVP & Chairman, PartneringSale29,400$1.66MForm 4
Jun 30, 2026Hite ChristopherEVP & Chairman, PartneringSale2,554$145.84KForm 4
Jun 30, 2026Hite ChristopherEVP & Chairman, PartneringSale97,446$5.51MForm 4
Jun 24, 2026Urist MarshallEVP, Research & InvestmentsSale9,098$502.07KForm 4
Jun 23, 2026Hite ChristopherEVP & Chairman, PartneringSale117,592$6.41MForm 4
Jun 23, 2026Hite ChristopherEVP & Chairman, PartneringSale32,408$1.75MForm 4
Jun 5, 2026Bassler Bonnie LDirectorAward4,545—Form 4
Jun 5, 2026Coric VladDirectorAward4,545—Form 4
Jun 5, 2026Ho CaroleDirectorAward4,545—Form 4
Jun 5, 2026LOVE TED WDirectorAward4,545—Form 4
Jun 5, 2026Engelbert Catherine M.DirectorAward4,545—Form 4
Jun 5, 2026HODGSON DAVID CDirectorAward4,545—Form 4
Jun 5, 2026WEATHERMAN ELIZABETH HDirectorAward4,545—Form 4
Jun 5, 2026Norden GregoryDirectorAward4,545—Form 4
May 26, 2026Coyne Terrance P.EVP & CFOSale64,399$3.48MForm 4
May 20, 2026Urist MarshallEVP, Research & InvestmentsSale13,684$721.84KForm 4
May 14, 2026Norden GregoryDirectorSale3,045$161.38KForm 4
May 14, 2026Urist MarshallEVP, Research & InvestmentsSale13,684$726.14KForm 4
May 6, 2026Hite ChristopherEVP & Vice ChairmanAward24,263—Form 4
May 6, 2026Coyne Terrance P.EVP & CFOAward24,263—Form 4
May 6, 2026Urist MarshallEVP, Research & InvestmentsAward18,197—Form 4
May 6, 2026Legorreta Pablo G.CEO, Chairman of the BoardAward143,821—Form 4
Apr 28, 2026Coyne Terrance P.EVP & CFOSale1,875$93.33KForm 4
Apr 28, 2026Coyne Terrance P.EVP & CFOSale32,916$1.64MForm 4
Apr 1, 2026Coyne Terrance P.EVP & CFOSale32,916$1.59MForm 4
Apr 1, 2026Coyne Terrance P.EVP & CFOSale1,875$90.62KForm 4
Mar 31, 2026Bassler Bonnie LDirectorAward815$37.47KForm 4
Mar 23, 2026Coyne Terrance P.EVP & CFOSale1,875$85.37KForm 4
Mar 23, 2026Coyne Terrance P.EVP & CFOSale32,916$1.50MForm 4
Mar 2, 2026Coyne Terrance P.EVP & CFOSale583$27.41KForm 4
Mar 2, 2026Coyne Terrance P.EVP & CFOSale1,292$60.30KForm 4
Mar 2, 2026Coyne Terrance P.EVP & CFOSale10,429$490.31KForm 4
Mar 2, 2026Coyne Terrance P.EVP & CFOSale22,487$1.05MForm 4
Feb 23, 2026Coyne Terrance P.EVP & CFOSale1,875$84.97KForm 4
Feb 23, 2026Coyne Terrance P.EVP & CFOSale32,916$1.49MForm 4
Feb 11, 2026Coyne Terrance P.EVP & CFOAward26,626—Form 4
Feb 11, 2026Legorreta Pablo G.CEO, Chairman of the BoardAward157,828—Form 4
Feb 11, 2026Hite ChristopherEVP & Vice ChairmanAward26,626—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related